Diagnostic accuracy of serum dickkopf-1 protein in diagnosis hepatocellular carcinoma: An updated meta-analysis.
Journal
Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R
Informations de publication
Date de publication:
Aug 2019
Aug 2019
Historique:
entrez:
9
8
2019
pubmed:
9
8
2019
medline:
21
8
2019
Statut:
ppublish
Résumé
To verify the accuracy of serum dickkopf-1 protein (DKK-1) in the diagnosis of hepatocellular carcinoma (HCC) by an updated meta-analysis. We searched potential eligible studies in PubMed and Embase before July 8, 2018. Sensitivity (SN), specificity (SP), positive likelihood ratio (PLR), negative likelihood ratio (NLR), summary receiver operating characteristics curve (sROC), and diagnostic odds ratio (DOR) were pooled with their 95% confidence intervals CIs) using a bivariate random-effects model. A total of 8 articles contained 10 studies on diagnosis of HCC with DKK-1 alone,7 articles contained 9 studies on diagnosis of HCC with a-fetoprotein (AFP) alone and 5 articles contained 7 studies on diagnosis of HCC with DKK-1 + AFP were identified. The pooled SN, SP, PLR, NLR, and DOR of DKK-1 alone, AFP alone and DKK-1 + AFP were 0.72 (95% CI: 0.70-0.75), 0.62 (95% CI:0.59-0.64) and 0.80 (95% CI:0.78-0.83), 0.86 (95% CI: 0.84-0.87), 0.82 (95% CI:0.80-0.84) and 0.87 (95% CI: 0.85-0.88), 4.91 (95% CI: 2.73-8.83), 3.60 (95% CI:2.01-6.44) and 6.18 (95% CI: 4.68-8.16), 0.32 (95% CI: 0.22-0.47), 0.49 (95% CI:0.40-0.60) and 0.20 (95% CI: 0.15-0.26), and 17.21 (95% CI: 9.10-32.57), 7.45 (95% CI:3.69-15.01) and 31.39 (95% CI: 23.59-43.20), respectively. The area under the sROC was 0.88, 0.70, and 0.92 for the 3 diagnostic methods. Serum DKK-1 + AFP showed a high accuracy for diagnosis of HCC, and serum DKK-1 alone had moderate accuracy as compared to a previous meta-analysis, while AFP alone owned an unsatisfied diagnostic behavior for HCC. Due to the limitations of the current analysis, further well-designed studies are needed to confirm the diagnostic value of DKK-1 and DKK-1 + AFP in HCC diagnosis.
Sections du résumé
BACKGROUND
BACKGROUND
To verify the accuracy of serum dickkopf-1 protein (DKK-1) in the diagnosis of hepatocellular carcinoma (HCC) by an updated meta-analysis.
METHODS
METHODS
We searched potential eligible studies in PubMed and Embase before July 8, 2018. Sensitivity (SN), specificity (SP), positive likelihood ratio (PLR), negative likelihood ratio (NLR), summary receiver operating characteristics curve (sROC), and diagnostic odds ratio (DOR) were pooled with their 95% confidence intervals CIs) using a bivariate random-effects model.
RESULTS
RESULTS
A total of 8 articles contained 10 studies on diagnosis of HCC with DKK-1 alone,7 articles contained 9 studies on diagnosis of HCC with a-fetoprotein (AFP) alone and 5 articles contained 7 studies on diagnosis of HCC with DKK-1 + AFP were identified. The pooled SN, SP, PLR, NLR, and DOR of DKK-1 alone, AFP alone and DKK-1 + AFP were 0.72 (95% CI: 0.70-0.75), 0.62 (95% CI:0.59-0.64) and 0.80 (95% CI:0.78-0.83), 0.86 (95% CI: 0.84-0.87), 0.82 (95% CI:0.80-0.84) and 0.87 (95% CI: 0.85-0.88), 4.91 (95% CI: 2.73-8.83), 3.60 (95% CI:2.01-6.44) and 6.18 (95% CI: 4.68-8.16), 0.32 (95% CI: 0.22-0.47), 0.49 (95% CI:0.40-0.60) and 0.20 (95% CI: 0.15-0.26), and 17.21 (95% CI: 9.10-32.57), 7.45 (95% CI:3.69-15.01) and 31.39 (95% CI: 23.59-43.20), respectively. The area under the sROC was 0.88, 0.70, and 0.92 for the 3 diagnostic methods.
CONCLUSIONS
CONCLUSIONS
Serum DKK-1 + AFP showed a high accuracy for diagnosis of HCC, and serum DKK-1 alone had moderate accuracy as compared to a previous meta-analysis, while AFP alone owned an unsatisfied diagnostic behavior for HCC. Due to the limitations of the current analysis, further well-designed studies are needed to confirm the diagnostic value of DKK-1 and DKK-1 + AFP in HCC diagnosis.
Identifiants
pubmed: 31393380
doi: 10.1097/MD.0000000000016725
pii: 00005792-201908090-00040
pmc: PMC6708942
doi:
Substances chimiques
DKK1 protein, human
0
Intercellular Signaling Peptides and Proteins
0
alpha-Fetoproteins
0
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e16725Commentaires et corrections
Type : ErratumIn
Références
BMC Med Res Methodol. 2006 Jul 12;6:31
pubmed: 16836745
Lancet Oncol. 2015 Jul;16(7):804-15
pubmed: 26088272
Methods Mol Biol. 2017;1619:3-21
pubmed: 28674873
Int J Biol Markers. 2018 Nov;33(4):353-363
pubmed: 30071741
World J Gastroenterol. 2015 Oct 7;21(37):10573-83
pubmed: 26457017
Cochrane Database Syst Rev. 2012 Sep 12;(9):CD002799
pubmed: 22972059
PLoS One. 2017 Sep 13;12(9):e0183880
pubmed: 28902891
BMC Med Res Methodol. 2003 Nov 10;3:25
pubmed: 14606960
Yonsei Med J. 2015 Sep;56(5):1296-306
pubmed: 26256972
J Clin Epidemiol. 2005 Sep;58(9):882-93
pubmed: 16085191
Hematology. 2015 Jun;20(5):267-71
pubmed: 25271869
Leuk Lymphoma. 2018 Nov;59(11):2670-2678
pubmed: 29582699
Scand J Gastroenterol. 2016 Sep;51(9):1133-7
pubmed: 27161933
Clin Res Hepatol Gastroenterol. 2017 Oct;41(5):543-553
pubmed: 28291627
Asian Pac J Cancer Prev. 2014;15(9):3915-20
pubmed: 24935574
Eur Rev Med Pharmacol Sci. 2015 Aug;19(15):2786-97
pubmed: 26241531
Liver Int. 2016 Jan;36 Suppl 1:124-9
pubmed: 26725909
Histopathology. 2015 Aug;67(2):158-66
pubmed: 24916146
Ann Intern Med. 2011 Oct 18;155(8):529-36
pubmed: 22007046
Asian Pac J Trop Med. 2017 Apr;10(4):409-413
pubmed: 28552111
Oncotarget. 2017 Aug 1;8(35):58974-58984
pubmed: 28938611
Gastroenterology. 2009 Jul;137(1):110-8
pubmed: 19362088
Anticancer Res. 2017 Sep;37(9):4881-4888
pubmed: 28870909
J Hepatol. 2012 Apr;56(4):908-43
pubmed: 22424438
Hepatol Int. 2017 Jul;11(4):317-370
pubmed: 28620797
Liver Int. 2011 Nov;31(10):1494-504
pubmed: 21955977
Radiology. 2016 Oct;281(1):150-7
pubmed: 27077381
Tumour Biol. 2015 Feb;36(2):1245-50
pubmed: 25344678
PLoS One. 2016 Mar 17;11(3):e0151069
pubmed: 26986465
Lancet Oncol. 2012 Aug;13(8):817-26
pubmed: 22738799
Oncotarget. 2017 Aug 7;8(52):90390-90401
pubmed: 29163838
Semin Diagn Pathol. 2017 Mar;34(2):153-159
pubmed: 28108047
Clin Biochem. 2014 Feb;47(3):196-200
pubmed: 24362268
Int J Biol Markers. 2014 Dec 09;29(4):e403-10
pubmed: 24980448
Med Oncol. 2014 Jul;31(7):966
pubmed: 24878698
Nature. 1998 Jan 22;391(6665):357-62
pubmed: 9450748
J Clin Epidemiol. 2009 Oct;62(10):e1-34
pubmed: 19631507
Med Oncol. 2015 Mar;32(3):59
pubmed: 25652109
Int J Biol Markers. 2013 Sep 27;28(3):286-97
pubmed: 23568769
Turk J Gastroenterol. 2016 Jul;27(4):375-81
pubmed: 27458854
Eur J Radiol. 2018 Apr;101:72-81
pubmed: 29571804
J Clin Gastroenterol. 2014 Oct;48(9):806-14
pubmed: 24247813
Hepatology. 2011 Mar;53(3):1020-2
pubmed: 21374666
CA Cancer J Clin. 2017 Jan;67(1):7-30
pubmed: 28055103
Gastroenterol Res Pract. 2014;2014:529314
pubmed: 25165471
Oncotarget. 2015 Aug 14;6(23):19907-17
pubmed: 26101916
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120